Patents Assigned to BIOFARMA S.R.L
  • COMPOSITION FOR USE IN THE TREATMENT OF GROUP-B STREPTOCOCCUS (GBS) INFECTIONS
    Publication number: 20230263840
    Abstract: The present invention concerns the field of bacterial infections, and in particular Group-B Streptococcus (GBS) infections during and after pregnancy. The present invention relates to the use of a composition comprising a strain of Lactobacillus acidophilus, a strain of Lactobacillus rhamnosus, and lactoferrin in the preventive and/or curative treatment of Group-B Streptococcus (GBS) infections.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 24, 2023
    Applicant: BIOFARMA S.R.L
    Inventor: Carlo Terruzzi